Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Allegations of Undisclosed Risks Plaintiffs assert that the manufacturers of Ozempic, Wegovy, Mounjaro, Victoza, Saxenda, Rybelsus, and other GLP-1 agonists failed to adequately warn consumers about the risk of these potentially life-altering side effects
March 5-8, 2026
Our experience across peptide research protocols shows that the 'which is better' question only makes sense once you've defined what outcome you're measuring
Drug interactions are most clinically important with insulin and sulfonylureas (hypoglycaemia risk), DPP-4 inhibitors (dont combine), and (for Mounjaro only) oral contraceptives and oral HRT
US$ 25.28
US$ 29.09
US$ 29.13
US$ 24.46
US$ 29.64
US$ 20.74
US$ 27.79
US$ 28.45
